Facio-Scapulo-Humeral Dystrophy
Neurology·MeSH: Muscular Dystrophy, Facioscapulohumeral
Prevalence
30.0 / 100K
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Facio-Scapulo-Humeral Dystrophy?
BioSniper tracks 2 drugs in development for Facio-Scapulo-Humeral Dystrophy across 1 company.
How many clinical trials target Facio-Scapulo-Humeral Dystrophy?
There are 3 clinical trials targeting Facio-Scapulo-Humeral Dystrophy tracked by BioSniper.
What is the prevalence of Facio-Scapulo-Humeral Dystrophy?
The estimated prevalence of Facio-Scapulo-Humeral Dystrophy is approximately 30.0 per 100,000 population.
Deep-dive into Facio-Scapulo-Humeral Dystrophy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis